Danh mục

Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)

Số trang: 11      Loại file: pdf      Dung lượng: 1.05 MB      Lượt xem: 9      Lượt tải: 0    
Jamona

Hỗ trợ phí lưu trữ khi tải xuống: 3,000 VND Tải xuống file đầy đủ (11 trang) 0
Xem trước 2 trang đầu tiên của tài liệu này:

Thông tin tài liệu:

Small-cell lung cancer (SCLC) is a highly aggressive and lethal malignancy that accounts for 10–15% of lung cancers, and it is generally divided into limited and extensive stage. The standard of care for patients with newly diagnosed extensive-stage SCLC (ES-SCLC) is still platinum-based chemotherapy and as maintenance therapy scheme.
Nội dung trích xuất từ tài liệu:
Efficacy and safety of fuzoparib combined with anlotinib in extensive stage small cell lung cancer after first-line platinum-based chemotherapy: A multi-center, single-arm prospective phase II clinical study (STAMP study)

Tài liệu được xem nhiều:

Tài liệu liên quan: